Since the 1990s, huge progress has been made in the fight against breast cancer. A study led by British scientists quantified this improvement.
And guess what, an impressive two-thirds reduction in mortality rates was reported!
Hi, I am Maria from Kieger.
The study, involving half a million women, found that the most critical period is within 5 years after diagnosis. Back in the 90s, a concerning 14% of early invasive breast cancer cases led to mortality within this timeframe.
For those diagnosed after 2010, the overall risk of succumbing to breast cancer was significantly lower at around 5%. But sadly the risk remains high for a few.
We need to keep investing in innovative diagnostics and treatments, promoting education and ensuring everyone has access to top-notch healthcare. These are some areas of investment at Kieger. Interested?
What mattered this month in healthcare? The readout of the SELECT study was the single biggest healthcare event of the month. The results may open the door to wide reimbursement for GLP-1 weight-loss drugs. This led to an overreaction with significant price movements amongst many companies as markets just made blanket assumptions of a healthier, thinner world. Find out more in our monthly healthcare newsletter.
What mattered this month in healthcare? Second quarter earnings season kicked off to a strong start, with earnings overall better than estimates. However, positioning matters, and strong numbers were not always enough if expectations were high. Find out more in our monthly healthcare newsletter.